 |
Corporate News
22-Aug-23
|
|
|
|
|
|
|
|
|
|
|
|
Piramal Pharma allots 12.96 cr equity shares on rights basis
|
|
|
|
|
|
|
|
Piramal Pharma has allotted 12,96,04,598 equity shares at a price of Rs 81 per equity share (including a premium of Rs 71 per equity share) on rights basis. Accordingly, pursuant to the Allotment, the paid-up equity share capital of the company has increased from Rs 1193,31,85,000 to Rs 1322,92,30,980.
|
|
|
|
Previous News |
Nifty hovers around 18,250; PSU banks slide
(
Market Commentary
-
Mid-Session
25-May-23
14:33
)
|
|
|
Piramal Pharma reports consolidated net loss of Rs 98.58 crore in the June 2023 quarter
(
Results
-
Announcements
04-Aug-23
07:42
)
|
|
|
Piramal Pharma to conduct AGM
(
Corporate News
-
29-May-23
12:49
)
|
|
|
Piramal Pharma rises after USA facility clears USFDA inspection
(
Hot Pursuit
-
18-Apr-24
09:40
)
|
|
|
Piramal Pharma gains after US facility gets EIR
(
Hot Pursuit
-
16-Feb-23
14:59
)
|
|
|
Volumes spurt at Fine Organic Industries Ltd counter
(
Hot Pursuit
-
25-May-23
14:30
)
|
|
|
Piramal Pharma Q1 net loss narrows to Rs 98 cr
(
Hot Pursuit
-
04-Aug-23
11:18
)
|
|
|
Piramal Pharma consolidated net profit declines 75.44% in the March 2023 quarter
(
Results
-
Announcements
25-May-23
07:41
)
|
|
|
Piramal Pharma grants 48.30 lakh stock options
(
Corporate News
-
26-Jul-24
10:05
)
|
|
|
Piramal Pharma reports consolidated net loss of Rs 88.64 crore in the June 2024 quarter
(
Results
-
Announcements
26-Jul-24
14:33
)
|
|
|
Piramal Pharma schedules board meeting
(
Corporate News
-
24-May-23
10:52
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|